STI PCR test products are core tools for sexually transmitted infection diagnosis, featuring high sensitivity, strong specificity and rapid detection via polymerase chain reaction technology. They enable early identification of pathogens like HPV, HSV and syphilis, critical for infection control and treatment. China's market integrates global advanced technology and local innovation, nurturing excellent brands. Below are the top 10 brands leading the industry's development.
1. INNOCHEK BIOTECH CO., LTD
INNOCHEK BIOTECH CO., LTD, are dedicating in delivering comprehensive, efficient, and innovative POCT solutions to global users.
The company was established 2017 and headquartered in Hongkong, is a conglomerate seamlessly integrating R&D, production, registration, sales, and marketing.
Leveraging microfluidics and electrochemical technologies, INNOCHEK has successfully developed a diverse range of key products, including blood gas and electrolytes, immunofluorescence, coagulation, and animal diagnostic series.
2. Roche Diagnostics
A global leader holding ~35% of China's STI PCR test market share. Its COBAS® series products excel in HPV and HIV detection, with high sensitivity and comprehensive pathogen coverage. The COBAS® 6800 system is widely used in Chinese hospitals, supporting automated batch testing. Leveraging strong R&D capabilities and brand influence, it maintains a leading position by cooperating with local institutions and continuously upgrading technologies.
3. Abbott Diagnostics
Ranking second in China's market with ~25% share, its Aptima® Assays product line is favored in gonorrhea and syphilis detection. The STI PCR kits feature high accuracy and convenient operation, compatible with mainstream laboratory equipment. It deepens cooperation with Chinese medical and research institutions, optimizing products for local clinical needs and expanding market penetration with a global service network.
4. Kehua Bio
China's first listed IVD enterprise, with profound experience in nucleic acid detection. Its STI PCR kits adopt multiple fluorescent quantitative technology, covering HBV, HCV and HIV-1/2 with ultra-high sensitivity. The products adapt to automated extraction equipment and integrated systems, meeting single and mixed testing demands. It holds core certifications and is widely used in blood screening and clinical diagnosis.
5. Bioer
A high-tech enterprise specializing in molecular diagnostics. Its STI-6 nucleic acid detection kit identifies six common pathogens via fluorescence PCR, with no cross-reactivity to non-target pathogens. The ready-to-use premix reduces manual errors, and the UDG system prevents contamination. Compatible with multiple PCR platforms, it is suitable for urine and swab samples, widely applied in primary medical institutions.
6. BD Company
Occupying ~15% of China's market, it is renowned for high-quality and reliable STI detection products. Its Pima® Line series combines PCR technology with rapid detection, enabling efficient diagnosis of HCV and other pathogens. It strengthens cooperation with local partners, optimizes sales and after-sales services, and meets diverse needs of hospitals and clinics with flexible product specifications.
7. Wantai Bio
A leading domestic IVD enterprise with mature STI PCR test technology. Its products cover syphilis, HIV and HPV detection, featuring stable performance and cost-effectiveness. Equipped with complete quality control systems, the kits comply with national medical standards. It focuses on technological iteration and channel expansion, gaining popularity in both primary and tertiary hospitals.
8. KingMed Bio
Specializing in nucleic acid diagnostic reagents, its STI PCR kits excel in HPV typing and chlamydia detection. Adopting advanced primer-probe design, the products ensure high specificity and low false-negative rates. It cooperates with clinical institutions to optimize product applicability, and its automated testing solutions improve laboratory workflow efficiency, occupying an important position in the domestic market.
9. Sansure Bio-tech
An innovative biotech enterprise with core technologies in molecular diagnostics. Its STI PCR products support rapid detection of multiple pathogens in a single test, with a detection time of less than 70 minutes. The kits are compatible with mainstream instruments and suitable for emergency testing scenarios. It focuses on technological innovation and cost control, providing high-performance products for medical institutions.
10. Randox
A global molecular diagnostic brand with a solid presence in China. Its STI qPCR assays detect 9 pathogens via four separate kits, supporting flexible batch testing. Validated for QuantStudio™ 5 systems, the products have a run time under 65 minutes and are compatible with urine and urogenital swabs. Equipped with internal controls, they prevent false negatives, serving middle and high-end medical institutions.